RecruitingNot Applicable

Comparing SBRT to CRT in Patients With Spinal Metastases

Canada100 participantsStarted 2022-12-12

Plain-language summary

This is a single institutional registry-based, prospective, observational study to describe radiation oncologists' decision making during evaluation of patients and to compare real-world outcomes of SBRT vs CRT. A registry-based trial involves observing the effect of something without manipulating it.

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults 18 years of age or older. * Patients seen at the Princess Margaret Cancer Centre with painful spinal metastases amenable to radiation treatment. * Confirmation of diagnosis: a) Known/documented prior histological cancer diagnosis * Able to provide written consent * ECOG performance status 0-3 Exclusion Criteria: * Prior radiotherapy, with fields overlapping, resulting in excessive doses to organs at risk * Lymphoma, myeloma or germ cell malignancies

What they're measuring

Describe physician decision-making when making a recommendation for SBRT vs CRT in spine metastasis patients requiring radiation.

Timeframe: 2 years

Trial details

NCT IDNCT05589701

SponsorUniversity Health Network, Toronto

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-12

Contact for this trial

David Shultz, MD

416-946-4501 david.shultz@rmp.uhn.ca

View on ClinicalTrials.gov More Spinal Metastases trials